A generation ago, the drug industry accounted for about a third of clinical trials, while academic medical centers, using largely government funds, accounted for two-thirds of the tests. Today, that ratio is reversed. One estimate I’ve seen suggested industry spends over $20 billion a year on clinical trials, well over half of its collective research and development budget.
The time has come to ask whether our privatized system of clinical trial research is serving the nation’s health. The fact that a drug like Zetia can be approved and sold to millions of people for nearly a decade without any evidence that it actually saves lives is absurd.
Conference on Retroviruses and Opportunistic Infections Rundown -- MK 5172 and 8742 Data Sets -- HCV/HIV Co-Infection - As we last discussed in detail -- back in March of 2012 -- an important consideration in treating any auto-immune system disorder is the likelihood of a c...
37 minutes ago